The Department of Health and Human Services and other federal agencies should work through the Biodefense Steering Committee to ensure the Biodefense Coordination Team defines the capabilities needed to prepare for and respond to significant biological incidents such as COVID-19; monitors and reports on findings from interagency exercises and real-world incidents; and recommends action to address identified challenges, according to a report released today by the Government Accountability Office. The Coronavirus Aid, Relief, and Economic Security Act called for GAO to review federal efforts to prepare for, respond to and recover from COVID-19. The agency reviewed interagency response plans and exercises and real biological incidents between 2009 and 2019 to identify opportunities to better achieve National Biodefense Strategy objectives.

Related News Articles

Headline
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee today by a unanimous vote recommended that the FDA issue an…
Perspective
For nearly 20 grueling months, hospitals and health systems — and their steadfast front-line caregivers — have risen to the incredible challenges caused by…
Headline
The Centers for Disease Control and Prevention today revealed the comparative effectiveness of the three Food and Drug Administration-authorized COVID-19…
Headline
The Centers for Disease Control and Prevention will invest $2.1 billion from the American Rescue Plan Act to help public health and other partners fight COVID-…
Headline
The Department of Health and Human Services’ Assistant Secretary for Preparedness and Response this week announced a major change in the distribution of…
Headline
The AHA has received a $1 million grant from the Centers for Disease Control and Prevention to continue for one year its efforts to encourage COVID-19…